Mylan settles with Apotex as Ranbaxy trial over alleged Provigil reverse payment gets under way


The following article first appeared on June 12 on MLex. For more information on MLex, including getting access to its exclusive content, please contact sales@mlex.com. Generic drugmaker Apotex, which sued over agreements between Cephalon and generic drugmakers that delayed generic entry of the sleep apnea drug Provigil, has reached